Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Grigorieva

Showing results (201-210 of 206) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 206 results.
Human Molecular Genetics|January 11, 2007
Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factorAsif Ali, Paul T Christie, Irina V Grigorieva, et al.
Nature Communications|July 31, 2024
Author Correction: Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cellsVictoria O Shender, Ksenia S Anufrieva, Polina V Shnaider, et al.
Nature Communications|June 19, 2024
Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cellsVictoria O Shender, Ksenia S Anufrieva, Polina V Shnaider, et al.
Kardiologiia|January 25, 2021
[International register "Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients (ACTIV SARS-CoV-2)"]G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.
Terapevticheskii Arkhiv|October 26, 2022
[ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis]G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.
Kardiologiia|October 29, 2021
Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)E I Tarlovskaya, A G Arutyunov, A O Konradi, et al.
Pageof 21

Showing results (201-210 of 206) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 206 results.
Human Molecular Genetics|January 11, 2007
Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factorAsif Ali, Paul T Christie, Irina V Grigorieva, et al.
Nature Communications|July 31, 2024
Author Correction: Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cellsVictoria O Shender, Ksenia S Anufrieva, Polina V Shnaider, et al.
Nature Communications|June 19, 2024
Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cellsVictoria O Shender, Ksenia S Anufrieva, Polina V Shnaider, et al.
Kardiologiia|January 25, 2021
[International register "Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients (ACTIV SARS-CoV-2)"]G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.
Terapevticheskii Arkhiv|October 26, 2022
[ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis]G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.
Kardiologiia|October 29, 2021
Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)E I Tarlovskaya, A G Arutyunov, A O Konradi, et al.
Pageof 21